Proterris Company
Proterris, a P2 clinical-stage firm, has pooled a dominant IP position in therapeutic uses of inhaled and small-molecule carbon monoxide.
Industry:
P4 Medicine
Headquarters:
Boston, Massachusetts, United States
Founded Date:
2005-01-01
Employees Number:
1-10
Total Funding:
1999999
Last Funding Type:
Venture - Series Unknown
Register and Claim Ownership